LAG3 and non-small cell lung carcinoma: More generally, NSCLC CD8+ PD-1-high vs. PD-1-negative TILS have coregulated expression of CTLA-4, TIM-3, LAG-3, and TIGIT, but anti-regulated expression of KLRG1 (Figure 1E).